Hangzhou Tigermed Consulting Co Ltd
SZSE:300347
Hangzhou Tigermed Consulting Co Ltd
SZSE:300347
Price:
51.17
CNY
Market Closed
Market Cap:
¥44.1B
Relative Value
The Relative Value of one
Hangzhou Tigermed Consulting Co Ltd
stock under the Base Case scenario is
43.79
CNY.
Compared to the current market price of 51.17 CNY,
Hangzhou Tigermed Consulting Co Ltd
is
Overvalued by 14%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
Relative Value
Base Case
43.79
CNY
Overvaluation 14%
Multiples Across Competitors
Competitors Multiples
Hangzhou Tigermed Consulting Co Ltd Competitors
Hangzhou Tigermed Consulting Co Ltd Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| CN |
|
Hangzhou Tigermed Consulting Co Ltd
SZSE:300347
|
43.7B CNY | 6.7 | 71.5 | 83.5 | 83.5 | |
| US |
P
|
PerkinElmer Inc
LSE:0KHE
|
947.7B USD | 331.8 | 3 929 | 1 125.9 | 2 168.1 | |
| US |
|
Thermo Fisher Scientific Inc
NYSE:TMO
|
178.5B USD | 4 | 26.5 | 18.5 | 24.9 | |
| US |
|
Danaher Corp
NYSE:DHR
|
133.8B USD | 5.5 | 37.2 | 18.9 | 27.5 | |
| KR |
|
Samsung Biologics Co Ltd
KRX:207940
|
82.3T KRW | 18.1 | 46.1 | 30.1 | 39.4 | |
| CH |
|
Lonza Group AG
SIX:LONN
|
32.5B CHF | 4.9 | 34.1 | 25.5 | 25.5 | |
| CN |
|
WuXi AppTec Co Ltd
SSE:603259
|
266.5B CNY | 6 | 17.8 | 17.8 | 17.8 | |
| US |
|
Agilent Technologies Inc
NYSE:A
|
31.6B USD | 4.5 | 24.5 | 18.1 | 21.3 | |
| US |
|
Waters Corp
NYSE:WAT
|
29.4B USD | 9.3 | 45.9 | 29.7 | 37.3 | |
| US |
|
IQVIA Holdings Inc
NYSE:IQV
|
28.2B USD | 1.7 | 20.8 | 11.7 | 17.5 | |
| US |
|
Mettler-Toledo International Inc
NYSE:MTD
|
24.4B USD | 6.1 | 28.4 | 21.2 | 23.5 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
